Pancreatic cancer patient-derived xenograft (PDX) RNAseq analyses to unravel the stromal impact on gemcitabin resistance acquisition
Jérôme Raffenne(Inserm), Corinne Bousquet(Centre National de la Recherche Scientifique), Alexia Brunel(Université Toulouse III - Paul Sabatier), Rémy Nicolle(Centre National de la Recherche Scientifique), Amandine Alard(Unknown), Christine Jean(Centre National de la Recherche Scientifique), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Rémi Samain(Inserm), Charles Theillet(Centre National de la Recherche Scientifique), Yvan Martineau(Centre National de la Recherche Scientifique), Ismahane Belhabib(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284